Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial

Gespeichert in:
Autor*in:

Loomba, Rohit [verfasserIn]

Noureddin, Mazen

Kowdley, Kris

Kohli, Anita

Sheikh, Aasim

Neff, Guy

Bhandari, Bal Raj

Gunn, Nadege T.

Caldwell, Stephen

Goodman, Zachary

Wapinski, Ilan

Resnick, Murray

Beck, Andrew

Ding, Dora

Jia, Catherine

Huss, Ryan

Chung, Chuhan

Subramanian, Mani

Myers, Robert

Patel, Keyur

Borg, Brian

Ghalib, Reem

Kabler, Heidi

Poulos, John

Younes, Ziad H.

Elkhashab, Magdy

Hassanein, Tarek

Iyer, Rajalakshmi

Ruane, Peter

Shiffman, Mitchell

Strasser, Simone

Wong, Vincent Wai-Sun

Alkhouri, Naim

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2020

Umfang:

2

Übergeordnetes Werk:

Enthalten in: Identification of the antigenic region of - Abdelbaky, Hanan H. ELSEVIER, 2018, official journal of the European Association for the Study of the Liver, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:73 ; year:2020 ; pages:116-117 ; extent:2

Links:

Volltext

DOI / URN:

10.1016/S0168-8278(20)30753-4

Katalog-ID:

ELV051437406

Nicht das Richtige dabei?

Schreiben Sie uns!